Loading...
Price History
Market Data
| Market Cap | -3.22B |
| P/E Ratio | 28.91 |
| P/B Ratio | -6.25 |
| EPS | 0.65 |
| Dividend Yield | - |
| D/E Ratio | 0.44 |
| Current Ratio | 2.73 |
| Currency | USD |
Key Financial Metrics
1.29B
Revenue
58.52M
Net Income
0.65
EPS (Diluted)
335.95M
Free Cash Flow
Profitability
Gross Margin
23.6%
Operating Margin
6.6%
Net Profit Margin
4.5%
EBITDA
93.65M
Returns & Efficiency
Return on Assets (ROA)
7.9%
Return on Equity (ROE)
11.3%
Dividend Yield
-
EPS
0.65
Financial Health
Total Assets
742.43M
Total Debt
-
Debt to Equity
0.44x
Current Ratio
2.73
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Health Services |
| HQ | NEW YORK, NY |
| Fiscal Year | 2025 |
Peers
DAVITA INC
DVA
12.54B
P/E: --
12.54B
P/E: --
DAVITA INC.
DVA
12.54B
P/E: --
SOTERA HEALTH CO
SHC
4.48B
P/E: 92.5
2.01B
P/E: 142.9
860.49M
P/E: --
463.98M
P/E: --
349.63M
P/E: 25.0
Quick Links
Financial Statistics
Valuation
Market Cap$-3.22B
P/E Ratio (TTM)28.9
Price to Book-6.25
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin23.6%
Operating Margin6.6%
Net Margin4.5%
ROE11.3%
ROA7.9%
Leverage & Liquidity
Debt to Equity0.44
Current Ratio2.73
Total Debt-
Total Assets$742.43M
Stockholders' Equity$516.04M
Income Statement (FY 2025)
Revenue$1.29B
Gross Profit$304.48M
Operating Income$85.28M
Net Income$58.52M
EPS (Diluted)$0.65
Cash Flow (FY 2025)
Free Cash Flow$335.95M
Cash & Equivalents$112.24M
Revenue Growth10.4%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 1359 BROADWAY 2ND FLOOR NEW YORK, NY 10018 |
| Phone | 212-888-3124 |
| Incorporated | DE, US |
| EIN | 272220139 |
| Fiscal Year End | 1231 |
| Shares Outstanding | -171.63M |
| Stockholders' Equity | $516.04M |
| Cash & Equivalents | $112.24M |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-07
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-16
Local
PRE 14A
Preliminary Proxy Statement
Preliminary proxy statement for SEC review
Filed: 2026-03-31
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-19
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-04
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-03
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-02
Local
S-8
Employee Plan Registration
Registration for employee benefit plan securities
Filed: 2026-02-27
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-27
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | PROGYNY, INC. |
| Ticker | PGNY |
| Exchange | -- |
| Sector | Services |
| Industry | Health Services |
| Headquarters | NEW YORK, NY |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | -3.22B |
| Revenue | 1.29B |
| Net Income | 58.52M |
| P/E Ratio | 28.91 |
| EPS | 0.65 |
| Net Margin | 4.5% |
| ROE | 11.3% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...